Plain-English translation of NCT05734300 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer surgical technique called Combined Endoscopic Laparoscopic Surgery (CELS) — which removes only the cancerous tumor and a small surrounding area — works as well as or better than traditional colon cancer surgery in older and frail patients. Standard colon cancer surgery removes a larger section of the colon along with nearby lymph nodes. This study is testing whether the newer, less invasive approach leads to faster recovery and better quality of life, especially for elderly or medically fragile patients.
Most early-stage colon cancers have a low risk of spreading to nearby lymph nodes, meaning many patients may not actually benefit from the larger removal of bowel tissue required by standard surgery. This trial exists to see if the newer technique can reduce surgery-related complications and improve recovery while still safely treating the cancer — particularly important for older or frail patients who face higher surgical risks.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the newer minimally invasive CELS technique or standard colon cancer surgery — both performed under general anesthesia. Your surgical team will monitor you during and after the operation, and you will be followed to assess your recovery, quality of life, and how well the cancer is controlled. The study is tracking outcomes in 48 patients overall to compare how the two approaches affect elderly and frail patients' recovery and well-being.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Denmark